Non-Invasive Pain Relief Solutions
Without the risks of surgery
Call For Appointments
+65 6732 2397 | +65 9068 9605 (after office hours)
Insurance, medisave & cashless options available
Back-pain injections are not interchangeable, and most people with uncomplicated back pain do not need one. An epidural or nerve-root injection may be considered for selected patients with acute, severe sciatica. A diagnostic medial branch block may help determine whether a carefully selected patient with chronic localised back pain should proceed to radiofrequency denervation. Sacroiliac-joint and trigger-point injections target different suspected pain sources. Routine spinal injections are not recommended for nonspecific back-only pain by NICE.[1]
The decision should begin with a clinical question: What structure or pain pathway is being targeted, why is it plausible in this patient, and what would a successful response allow the patient to do? An injection may reduce symptoms temporarily, but it does not automatically repair a disc, reverse degeneration or remove the need for rehabilitation.
Seek urgent medical assessment for new difficulty passing urine, loss of bladder or bowel control, numbness around the genitals or anus, rapidly worsening weakness, severe symptoms in both legs, major trauma, fever with serious illness or another major warning sign. An outpatient injection must not delay emergency assessment or surgery when urgent nerve compression or another serious condition is suspected.
| Procedure | Usual target or purpose | Typical patient question |
|---|---|---|
| Epidural steroid injection | Inflammation around a spinal nerve in selected radicular pain or sciatica | “Severe leg pain is preventing sleep or rehabilitation. Could temporary relief help?” |
| Selective nerve-root block | A particular exiting nerve root; may have diagnostic and therapeutic aims | “Do my symptoms and MRI point to one nerve root?” |
| Facet-joint injection or medial branch block | A facet joint or the small nerves supplying it; often used to test a suspected pain source | “Is my localised back pain arising from facet-mediated pathways?” |
| Radiofrequency denervation | Heat lesioning of selected medial branch nerves after an appropriate positive diagnostic block | “Did the test block provide enough relief to justify a longer-acting procedure?” |
| Sacroiliac-joint injection | The joint between the sacrum and pelvis; may assist diagnosis or provide temporary treatment | “Is pain below the belt line coming from the sacroiliac joint rather than the lumbar spine or hip?” |
| Trigger-point or soft-tissue injection | A clinically identified painful muscle or soft-tissue region | “Is there a local muscular target, and will treating it change function?” |
| Biologic or regenerative injection | Proposed disc, joint or soft-tissue targets using products such as platelet-rich plasma or cell-related preparations | “Is this established care, an emerging option or an experimental intervention?” |
Back-only pain may remain around the lower back, upper buttocks or waist and often cannot be attributed confidently to one structure. Sciatica generally refers to pain associated with a lumbar nerve root, often travelling into the leg and sometimes accompanied by tingling, numbness, weakness or altered reflexes.
This distinction matters because an epidural steroid injection is aimed more plausibly at radicular leg pain than at nonspecific back-only pain. NICE advises against spinal injections for managing low back pain but recommends considering epidural local anaesthetic and steroid in people with acute and severe sciatica.[1]
Leg pain is not automatically sciatica. Hip disease, peripheral nerve problems, vascular conditions and referred musculoskeletal pain can produce overlapping symptoms. Examination should consider strength, sensation, reflexes, gait and symptom distribution before an injection target is selected.
The epidural space lies around the spinal nerve structures. An epidural injection usually places a corticosteroid with or without local anaesthetic into this space using an approach selected for the anatomy and clinical target. Common lumbar approaches include transforaminal, interlaminar and caudal routes.
The goal is usually to reduce inflammatory irritation around a nerve root and create a period of reduced leg pain. It does not remove a disc herniation or widen a narrowed spinal canal. If relief occurs, the patient may be better able to sleep, walk, work within limits or participate in rehabilitation while natural recovery continues.
The average benefit is limited and tends to be short term. A 2025 American Academy of Neurology systematic review found that epidural steroid injections probably reduce short-term pain and disability modestly in radiculopathy. Evidence for long-term pain relief was insufficient, although there may be some longer-term disability benefit. For lumbar spinal stenosis, injections may modestly reduce disability but were not shown to reduce short-term pain.[2]
Average research results do not predict an individual response. A patient with severe recent leg-dominant pain and matching examination and MRI findings is different from a patient with years of diffuse back-only pain and no clear nerve target.
A clinician may consider it when:
It is less compelling when pain is mainly nonspecific and confined to the back, the MRI finding does not match symptoms, the target is uncertain or repeated injections have provided no meaningful functional benefit.
A selective nerve-root injection is placed near a particular spinal nerve as it exits. Local anaesthetic may help test whether temporarily numbing that region changes the patient’s familiar pain; corticosteroid may be added for a therapeutic aim.
“Selective” does not mean perfectly specific. Injectate can spread, pain can fluctuate and placebo or non-specific effects can influence the response. The result should be interpreted alongside the history, examination and imaging rather than treated as an infallible diagnostic test.
Facet joints are small paired joints at the back of the spine, supplied by medial branch nerves. Localised pain may raise suspicion of facet-mediated pain, but symptoms, tenderness and imaging alone cannot prove the source.
A facet-joint injection places medication into or near the joint. A medial branch block places local anaesthetic near the small nerves supplying the suspected joint. The block is commonly used as a diagnostic or prognostic step before radiofrequency denervation rather than as a promise of lasting treatment.
NICE does not recommend routine therapeutic spinal injections for low back pain. It recommends considering referral for radiofrequency assessment only for selected patients with chronic localised pain thought to arise from structures supplied by the medial branch nerve, after non-surgical treatment has not worked and when pain is moderate or severe.[1]
Radiofrequency denervation—also called radiofrequency ablation or neurotomy—uses a needle electrode to heat a small target area around selected sensory nerves. The intention is to interrupt pain signalling from a suspected facet-mediated source for longer than a local anaesthetic block.
NICE recommends performing lumbar radiofrequency denervation only after a positive response to a diagnostic medial branch block.[1] International consensus guidance similarly concludes that lumbar medial branch radiofrequency treatment may benefit well-selected patients, with medial branch blocks generally more predictive than injections placed inside the facet joint.[3]
Nerves can recover, pain can recur and technical success does not guarantee functional improvement. The consent discussion should address the exact technique and risks.
The sacroiliac joints connect the sacrum to the pelvis. Pain is often felt below the belt line, near one buttock, but lumbar, hip and soft-tissue conditions can feel similar. No single symptom or examination manoeuvre proves that the joint is responsible.
An image-guided injection may place local anaesthetic and sometimes corticosteroid into the joint. A marked temporary response to local anaesthetic may support the diagnosis, while steroid is intended to provide longer relief. Evidence is mixed, techniques and patient selection vary, and benefit may be temporary. A 2024 systematic review found that corticosteroid was the most studied injective approach but also reported failures and complications, underlining the need for appropriate selection and follow-up.[4]
An injection should not end the diagnostic process if the response is absent or ambiguous. Hip assessment, lumbar examination and consideration of inflammatory sacroiliitis may still be needed.
A trigger-point injection places a needle, sometimes with local anaesthetic or another injectate, into a painful muscle region. It may be considered when examination identifies a reproducible local soft-tissue target. Dry needling uses a needle without injecting medication.
The definition of a trigger point and the evidence for different injectates are inconsistent. Temporary local relief does not prove that muscle tissue was the sole cause of a complex back-pain problem. A reasonable trial should connect relief to a functional goal and should stop if repeated treatment does not create meaningful progress.
Not every injection requires the same investigation. The clinician should first decide whether the suspected diagnosis is based on the symptom pattern and examination. Relevant assessment may include:
MRI may be appropriate when the result will confirm a plausible target, exclude a concerning alternative or inform an intervention or surgical opinion. Imaging should not be ordered merely to satisfy a routine sequence. The American College of Radiology considers lumbar MRI usually appropriate when a patient with persistent or progressive symptoms is a surgery or intervention candidate after appropriate management.[5]
Fluoroscopy, CT or ultrasound may help the clinician place a needle at the intended target and avoid surrounding structures. The most appropriate method depends on the procedure and anatomy. Contrast may be used in some image-guided spinal procedures to help confirm spread and reduce the risk of unintended placement.
Risks differ by route, level, medication and patient. Possible complications include:
The US Food and Drug Administration has warned that epidural corticosteroid injection may cause rare but serious events including loss of vision, stroke, paralysis and death. It also notes that corticosteroids are not approved by the FDA specifically for injection into the epidural space.[6] Regulatory wording and clinical practice differ by country, but the warning illustrates why informed consent and careful technique matter.
Before a procedure, provide a complete list of prescription medicines, over-the-counter products and supplements. Do not independently stop anticoagulants or antiplatelet medicines; stopping can create serious clotting risk, while continuing may increase bleeding risk. The prescribing and procedural clinicians should coordinate an individual plan.
There is no responsible universal number. The decision depends on the diagnosis, route, steroid exposure, response, risks and available alternatives. Repeating an injection that produced no meaningful benefit is difficult to justify unless there is a clear reason the first procedure did not adequately test the intended target.
Before repeating, record how much the familiar pain changed, how long benefit lasted, whether walking, sleep, work or rehabilitation improved and which adverse effects occurred. Brief relief without functional gain may not justify repeated exposure.
A medical assessment should confirm that the pattern is consistent with radiculopathy and check for neurological loss. If pain is acute and severe, imaging and an epidural or selective nerve-root pathway may be discussed. The expected benefit is usually temporary and modest on average, but that window may be valuable if it supports sleep and movement.
An epidural is generally less plausible without radicular symptoms or another defined indication. NICE advises against spinal injections for nonspecific low back pain. Reassessment should consider rehabilitation, medication safety, sleep, work demands and whether another diagnosis is present.
Failure of appropriate non-surgical care may prompt reassessment. If the pain pattern is thought to arise from structures supplied by medial branch nerves, a diagnostic block may be considered as part of a radiofrequency pathway. This is not the same as offering a routine facet steroid injection to everyone with degeneration on MRI.
A procedure cannot guarantee recovery within days. Discuss whether temporary pain reduction would actually make work safe, what restrictions are needed and how sedation or temporary numbness could affect driving or machinery. A rapid plan may combine medical management, temporary duty modification and rehabilitation.
More abnormalities do not justify more injections. The target should match the side and distribution of symptoms and relevant examination findings. When several findings are plausible, a carefully selected diagnostic block may provide information, but the result is not perfectly specific.
Duration and functional effect matter. Review whether the response matched the expected action of the injectate and whether the period of relief was used to rebuild capacity. Recurrence may lead to repeat treatment, a different procedure, further rehabilitation or a change of diagnosis; it should not automatically trigger an identical injection.
An injection may sometimes postpone or reduce the immediate need for surgery, but it cannot reliably correct severe mechanical compression or progressive neurological loss. When weakness is worsening or cauda equina compression is suspected, delaying surgical assessment to try repeated injections may be unsafe.
These approaches differ substantially. Some use a patient’s blood-derived product; others use cell-related products, gases, chemicals, heat, mechanical devices or treatments delivered into a disc. Early studies may suggest possible benefit for selected groups, but protocols, product quality, diagnosis, comparison groups and long-term safety vary.
Questions to ask include:
Evidence, regulatory status and professional guidance for emerging injections can change. A treatment discussed overseas may not be approved, routinely available or professionally appropriate in Singapore. Therapeutic products generally require Health Sciences Authority registration before supply, and clinical-trial or other requirements may apply.[7] Mention in this guide does not mean that a treatment is recommended or offered by The Pain Relief Clinic.
Record pain and function before treatment. Useful outcomes include:
A procedure should be reviewed at an appropriate interval. New weakness, fever, loss of bladder or bowel control, severe headache, increasing redness or another concerning post-procedure symptom requires prompt advice or urgent assessment according to severity.
The Pain Relief Clinic can provide assessment by a licensed medical doctor for back pain, sciatica or symptoms that have not improved with previous care. The consultation may include review of symptom distribution, neurological and musculoskeletal examination, current medicines, health risks, previous procedures and existing imaging.
Depending on the findings, the next plan may include explanation and monitoring, medication review, tailored physiotherapy, selected non-invasive treatment, imaging when clinically indicated or referral to an appropriate procedural or surgical service. The presence of pain or an MRI abnormality does not automatically mean that an injection is needed.
Not every injection or treatment discussed in this guide is suitable or offered by the clinic, and no procedure can guarantee permanent pain elimination.
For a non-emergency assessment, call or WhatsApp +65 9068 9605.
There is no best injection for all back pain. The appropriate target depends on whether symptoms are consistent with radiculopathy, facet-mediated pain, sacroiliac pain, a local soft-tissue problem or another diagnosis. Many patients should not have an injection.
They overlap but are not identical terms. Both may place medication near spinal nerve structures, while a selective nerve-root block is directed at a particular exiting nerve and may have a diagnostic purpose. Route and intended spread should be explained.
No. It may reduce inflammatory nerve-root pain while the condition recovers or other treatment continues. It does not physically return a disc to its original shape.
Not every peripheral or soft-tissue injection requires MRI. For a spinal procedure, imaging is often important when it confirms the anatomy, matches a neurological pattern or guides an intervention. The need depends on the procedure and clinical question.
Requirements vary. Some procedures use local anaesthetic alone; others may involve sedation. Sedation can affect driving, decision-making and post-procedure monitoring, so patients need specific instructions and transport arrangements.
Do not stop them independently. Continuing may increase procedural bleeding risk, but stopping may cause a serious clot, stroke or other event. The procedural clinician and the prescriber should give an individual plan.
It varies from no benefit to temporary or occasionally longer relief, depending on diagnosis, procedure and patient. Ask for a realistic range rather than a guarantee, and agree on how benefit will be measured.
Medical disclaimer: This article provides general educational information and is not a diagnosis, consent discussion or personalised recommendation for an injection or procedure. Suitability depends on an individual clinical assessment, imaging when indicated, current medicines and medical risks. Seek urgent medical attention for new bladder or bowel dysfunction, saddle numbness, severe bilateral symptoms, rapidly worsening weakness or other emergency features.
Find out how your pain can be more effectively treated.
For enquiries, Call +65 6732 2397